【正文】 不良反應(yīng)處理指南.5．Al Ghonaim M，Pannu N. Prevention and treatment of contrastinduced nephropathy. Tech Vasc Interv Radiol，2006，9： 4249.6．McCullough PA，Adam A，Becker CR，et al. Epidemiology and prognostic implications of contrastinduced nephropathy. Am J Cardiol，2006； 98： 5K13K.7．McCullough P. Outes of contrastinduced nephropathy： experience in patientsundergoing cardiovascular intervention. Catheter Cardiovasc Interv，2006； 67： 335343.8．Pannu N，Wiebe N，Tonelli strategies for contrastinduced nephropathy. JAMA，2006； 295： 27652779.9．ESUR對(duì)比劑指南. ：//10．Namasivayam S，Kalra MK，Torres WE et al . Adverse reactions to intravenous iodinated contrast media： a primer for Radiol. 2006； 12（5）： 210215.11．Webb JA，Stacul F，Thomsen HS et al. Members of the Contrasr Media Safety Committee of the European Society of Urogenital Radiology （ESUR）.Late adverse reactions to intravascular iodinated contrast Radiol. 2003；13：181184.12．Tepel M，Aspelin P，Lameire N. Contrastinduced nephropathy： a clinical and evidencebased approach. Circulation，2006； 113： 17991806.13．Persson PB，Tepel M. Contrast mediuminduced nephropathy： the pathophysiology. Kidney Int Suppl，2006； S8S10.14．Persson PB，Contrastinduced nephropathy （Review），Eur Radiol，2005； 15（Suppl 4）： D65D69.15．Morcos SK，Thomsen HS. European society of urogenital radiology guidelines on admininstering contrast media. Abdom Imaging，2003，28： 187190.16．Elicker BM，Cypel YS，Weinreb JC. IV contrast administration for CT： a survey of practices for the screening and prevention of contrast nephropathy. AJR，2006； 186： 1651165817．Thomsen HS. Guidelines for contrast media from the European Society of U rogenital Radiology. AJR Am J Roentgenol ， 2003； 181： 14631471.18．Richared Solomon. Kidney International. 2005； （68）： 2256 – 2263.19．American College of Radiology：Manual on contrast media（version 6）.：：//20．van der Molen AJ，Thomsen HS，Morcos SK. Effect of iodinated contrast media on thyroid function in adults. Eur ；14（5）：902907.21．Yamaguchi K，Katayama H，Takashima T，et al. Prediction of severe adverse reaction to ionic and nonionic contrast media in Japan： evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology，1991； 178： 363367.22．Widmark JM. Imagingrelated medications： a class overvies. Proc（Bay Univ Med Cent），2007，20： 408417. 23．Singh J，Daftary contrast media and their adverse reactions：J Nucl Med Technol. 2008；36（2）：6974.24．Thomsen HS，Morcos SK. ESUR guidelines on contrast ；31（2）：13114.25．Thomsen HS，Morcos SK. Contrastmediuminduced nephropathy： is there a new consensus? A review of published guidelines. Eur Radiol，2006； 16： 18351840. 26．Toprak O. Conflicting and new risk factors for contrast induced nephropathy （Review）. J Urol，2007，178： 22772283.27．Toprak O，Cirit M，Yesil M，et al. Impact of diabetic and prediabetic state on development of contrastinduced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant，2007，22： 819826.28．Rao QA，Newhouse JH. Risk of nephropathy after intravenous administration of contrast material： a critical literature analysis. Radiology，2006； 239： 392397.29．Toprak O，Cirit M. Risk factors and therapy strategies for contrastinduced nephropathy. Ren Fail，2006； 28： 365381.30．Katzberg RW，Barrett BJ. Risk of iodinated contrast material： induced nephropathy with intravenous administration. Radiology，2007； 243： 622628.31．李彪，齊海海，裕東潔，等. CockroftGault 公式和簡(jiǎn)化MDRD公式估算老年人腎功能準(zhǔn)確性的比較研究. 中華老年醫(yī)學(xué)雜志，2007； 26： 97100.32．Lameire N，Adam A，Becher CR，et al. Baseline renal function screening. Am J Cardiol，2006； 98： 21K26K.33．McCullough PA，Adam A，Becker C，et al. Risk prediction of contrastinduced nephropathy. Am J Cardiol. 2006；98（6 suppl 1）：2736.34．Namasivayam S，Kalra MK，Torres WE，et al. Adverse reactions to intravenous iodinated contrast media： a primer for radiologists. Emerg Radiol，2006； 12：210215.35．Solomon R. The role of osmolality in the incidence of contrastinduced nephropathy： a systemtic review of angiographic contrast media in high risk patients. Kidney Int，2005； 68： 22562263.36．Lameire N，Adam A，Becker C，et al. Baseline renal function screening. Am J Cardiol. 2006； 98（6 suppl 1）：2126.37．Ma YC，Li Z， Chen JH，et al. Modified Glomeruar Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease J Am Soc Nephrol. 2006；17：29372944.38．急性ST段抬高心肌梗死PCI的專家共識(shí).39．Weisbord SD，Palevsky PM. Prevention of contrastinduced nephropathy with volume J Am Soc Nephrol. 2008；3： 273280.40．Mueller C，Buerkle G，Buettner HJ ，et al. Prevention of contrast mediaassociated mephropathy： randomized parison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intem Med ，2002 ，162 ：329336.41．Merten GJ ，Burgess WP，Gray LV ，et al Prevention of contrastinducedinduced Nephropathy with sodium bicarbonate： a randomized controlled trial. JAMA，2004； 291： 23282334.42．Solomon RJ，Natarajan MK，Doucet S，et al. Cardiac Angiography in Renally Impaired Patients （CARE） study： a randomized doubleblind trial of contrastinduced nephropathy in patients with chronic kidney disease. Circulation. 2007；115：3189 –96.43．Reed M，Meier P，Tamhane UU，et al. The relative renal safety of iodixanol pared with lowosmolar contrast media： a metaanalysis of randomized contr